# Ribavirin

NDC: 42494-423
Generic name: Ribavirin
Labeler / Manufacturer: Cameron Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SOLUTION
Routes: RESPIRATORY (INHALATION)
Marketing started: 20200415
Marketing ended: 20260630
FDA application: NDA018859

## Active ingredients

- RIBAVIRIN: 6 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42494-423"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42494-423
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ea8dafa-d3d8-493e-a0db-e783d92fb13f